366 related articles for article (PubMed ID: 29466791)
1. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophy and Fibrosis of the Ligamentum Flavum in Lumbar Spinal Stenosis is Associated With Increased Expression of LPA and LPAR1.
Zhang K; Sun W; Liu XY; Zhao CQ; Li H; Sun XJ; You-Zhuan X; Ding W; Zhao J
Clin Spine Surg; 2017 Apr; 30(3):E189-E191. PubMed ID: 28323698
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
[TBL] [Abstract][Full Text] [Related]
4. Locally Produced IGF-1 Promotes Hypertrophy of the Ligamentum Flavum via the mTORC1 Signaling Pathway.
Yan B; Huang M; Zeng C; Yao N; Zhang J; Yan B; Jiang H; Tian X; Ao X; Zhao H; Zhou W; Chu J; Wang L; Xian CJ; Zhang Z; Wang L
Cell Physiol Biochem; 2018; 48(1):293-303. PubMed ID: 30016763
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid enhances human umbilical cord mesenchymal stem cell viability without differentiation via LPA receptor mediating manner.
Li N; Yan YL; Fu S; Li RJ; Zhao PF; Xu XY; Yang JP; Damirin A
Apoptosis; 2017 Oct; 22(10):1296-1309. PubMed ID: 28766061
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
Lee GH; Cheon J; Kim D; Jun HS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142408
[TBL] [Abstract][Full Text] [Related]
8. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Li HY; Oh YS; Choi JW; Jung JY; Jun HS
Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress mediates age-related hypertrophy of ligamentum flavum by inducing inflammation, fibrosis, and apoptosis through activating Akt and MAPK pathways.
Chuang HC; Tsai KL; Tsai KJ; Tu TY; Shyong YJ; Jou IM; Hsu CC; Shih SS; Liu YF; Lin CL
Aging (Albany NY); 2020 Nov; 12(23):24168-24183. PubMed ID: 33223505
[TBL] [Abstract][Full Text] [Related]
10. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
[TBL] [Abstract][Full Text] [Related]
11. Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats.
Chen X; Walther FJ; van Boxtel R; Laghmani EH; Sengers RM; Folkerts G; DeRuiter MC; Cuppen E; Wagenaar GT
Acta Physiol (Oxf); 2016 Mar; 216(3):358-75. PubMed ID: 26495902
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway.
Won KJ; Goh YJ; Hwang SH
Molecules; 2020 Mar; 25(7):. PubMed ID: 32230890
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line.
Zhang Z; Liu Z; Meier KE
Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1089-98. PubMed ID: 16760261
[TBL] [Abstract][Full Text] [Related]
14. ADAM10 promotes the proliferation of ligamentum flavum cells by activating the PI3K/AKT pathway.
Pan B; Huo T; Cao M; Jing L; Luo X; Qu Z; Feng H; Yuan F; Guo K
Int J Mol Med; 2021 Feb; 47(2):688-698. PubMed ID: 33416124
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
16. LPA
Wang F; Liu S; Pei J; Cai L; Liu N; Liang T; Dong X; Cong X; Chun J; Chen J; Hu S; Chen X
Theranostics; 2020; 10(24):10892-10907. PubMed ID: 33042260
[No Abstract] [Full Text] [Related]
17. Lysophosphatic acid modulates prostaglandin secretion in the bovine uterus.
Woclawek-Potocka I; Komiyama J; Saulnier-Blache JS; Brzezicka E; Bah MM; Okuda K; Skarzynski DJ
Reproduction; 2009 Jan; 137(1):95-105. PubMed ID: 18829944
[TBL] [Abstract][Full Text] [Related]
18. Leptin-induced inflammation by activating IL-6 expression contributes to the fibrosis and hypertrophy of ligamentum flavum in lumbar spinal canal stenosis.
Sun C; Wang Z; Tian JW; Wang YH
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29436483
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
Hurst JH; Hooks SB
Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
[TBL] [Abstract][Full Text] [Related]
20. LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.
Leve F; Peres-Moreira RJ; Binato R; Abdelhay E; Morgado-Díaz JA
PLoS One; 2015; 10(9):e0139094. PubMed ID: 26418031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
